ATR
Aptargroup·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Dividend Aristocrat
Consensus Rating "Buy"
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ATR
Aptargroup, Inc.
A global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services
265 Exchange Drive, Suite 301, Crystal Lake, IL 60014
--
Aptargroup, Inc., was incorporated in Delaware in 1992. The company is a global leader in the design and manufacture of dosing, dispensing and protection technologies for pharmaceuticals and consumer products. Aptargroup serves a number of attractive end markets including pharmaceuticals, beauty, food, beverages, personal care and home care. Leveraging market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptargroup in turn brings meaningful change to the lives, looks, health and homes of millions of patients and consumers around the world.
Earnings Call
Q1/2025
Estimate EPS1.15
Actual EPS1.2
Estimate Revenue898.64M
Actual Revenue887.30M
AptarGroup's Q1 2025: Navigating Contradictions in Inventory, Tariffs, and Demand Trends
May 02,2025 07:28
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS1.59
Actual EPS1.66
Estimate Revenue956.86M
Actual Revenue966.00M
AptarGroup's Q2 2025: Unpacking Contradictions in Pharma Growth, Legal Costs, and Beauty Segment Challenges
Aug 01,2025 03:10
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS1.57
Actual EPS1.62
Estimate Revenue951.88M
Actual Revenue961.13M
AptarGroup's Q3 2025: Contradictions Emerge on Emergency Medicine Growth, Inventory Normalization, Beauty Segment, and Legal Expenses
Nov 01,2025 06:03
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ATR has released its 2025 Q3 earnings. EPS was reported at 1.62, versus the expected 1.57, beating expectations. The chart below visualizes how ATR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ATR has released its 2025 Q3 earnings report, with revenue of 961.13M, reflecting a YoY change of 5.70%, and net profit of 127.83M, showing a YoY change of 27.93%. The Sankey diagram below clearly presents ATR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
